Dolby Laboratories (NYSE:DLB) Reaches New 12-Month Low – Time to Sell?

Shares of Dolby Laboratories (NYSE:DLBGet Free Report) reached a new 52-week low during trading on Thursday . The company traded as low as $51.91 and last traded at $52.5180, with a volume of 18730 shares trading hands. The stock had previously closed at $52.89.

Analysts Set New Price Targets

Several brokerages recently commented on DLB. Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research note on Thursday. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $90.75.

Check Out Our Latest Stock Report on DLB

Dolby Laboratories Trading Down 0.3%

The stock’s fifty day moving average price is $58.38 and its 200 day moving average price is $62.20. The stock has a market cap of $4.98 billion, a P/E ratio of 20.79 and a beta of 0.81.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. The company had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, analysts anticipate that Dolby Laboratories will post 3.21 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 annualized dividend and a dividend yield of 2.7%. Dolby Laboratories’s dividend payout ratio is 56.92%.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 7,666 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $55.62, for a total value of $426,382.92. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at $6,603,595.74. This represents a 6.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $54.90, for a total transaction of $164,700.00. Following the transaction, the senior vice president owned 80,603 shares in the company, valued at $4,425,104.70. The trade was a 3.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 39,791 shares of company stock valued at $2,231,653. 37.93% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Dolby Laboratories

A number of institutional investors have recently made changes to their positions in the business. Norges Bank bought a new stake in Dolby Laboratories in the fourth quarter worth $54,966,000. AQR Capital Management LLC grew its stake in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after buying an additional 592,282 shares during the last quarter. First Trust Advisors LP grew its stake in shares of Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after buying an additional 374,405 shares during the last quarter. Alyeska Investment Group L.P. purchased a new position in shares of Dolby Laboratories in the fourth quarter worth about $23,477,000. Finally, Voloridge Investment Management LLC increased its holdings in shares of Dolby Laboratories by 2,017.9% in the fourth quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker’s stock worth $20,904,000 after buying an additional 310,130 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Articles

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.